Savita Rangarajan

Publications

90 publications

Page 5 of 9

Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A

Johnny Mahlangu, Margaret Ragni, Naresh Gupta, Savita Rangarajan, Robert Klamroth, Johannes Oldenburg, Keiji Nogami, Guy Young, Lynda Cristiano, Yingwen Dong, Geoffrey Allen, Glenn Pierce & Brian Robinson, 2016, Thrombosis and Haemostasis, 116(07), 1-8

DOI: 10.1160/TH15-10-0780

Type: article

Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A

Paul Batty, Gary W Moore, Sean Platton, James C Maloney, Ben Palmer, Louise Bowles, K John Pasi, Savita Rangarajan & Daniel P Hart, 2015, Thrombosis and Haemostasis, 114(4), 804-811

DOI: 10.1160/TH14-12-1062

Type: article

Inhibitors in nonsevere haemophilia A

Alice S van Velzen, Corien L Eckhardt, Daniel P Hart, Marjolein Peters, Savita Rangarajan, Maria Elisa Mancuso, Frans J Smiers, Kate Khair, Pia Petrini, Victor Jiménez-Yuste, Charles R M Hay, Johanna G van der Bom, Thynn T Yee & Karin Fijnvandraat, 2015, Thrombosis and Haemostasis, 114(1), 46-55

DOI: 10.1160/TH14-11-0940

Type: article

[Accepted Abstracts: 2015 Scientific Symposium of the Hemostasis and Thrombosis Research Society April 16-18, 2015 New Orleans, Louisiana] Pharmacokinetic (PK) Comparison of Two Fibrinogen Concentrates for the Treatment of Congenital Fibrinogen Deficiency

Savita Rangarajan, M. Karimi, B. Schwartz, Sigurd Knaub & Flora Peyvandi, 2015, Haemophilia, 21(3), e271-e272

Type: conference

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor VIII: a prospective cohort comparison

C. R. M. Hay, B. P. Palmer, E. A. Chalmers, D. P. Hart, R. Liesner, S. Rangarajan, K. Talks, M. Williams & P. W. Collins, 2015, Haemophilia, 21(2), 219-226

DOI: 10.1111/hae.12563

Type: article

[Poster Presentations] Long-Term Safety and Efficacy of Recombinant Factor VIII FC (RFVIIIFC) in Adults and Adolescents With Severe Haemophilia A: An Interim Analysis of The ASPIRE Study

J. Pasi, D. Perry, J. Mahlangu, B. Konkle, S. Rangarajan, S.A. Brown, H. Hanabusa, S. Jackson, I. Pabinger, L. M. Cristiano, X. Li, G.F. Pierce & G. Allen, 2015, Haemophilia, 21(S2), 52-53

Type: conference

[Poster Presentation] Nonacog Beta Pegol (N9-GP) In Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Paediatric Haemophilia B Patients

M. Carcao, M. Zak, F.A. Karim, H. Hanabusa, S. Kearney, Y.M. Lu, P. Persson, S. Rangarajan & E. Santagostino, 2015, Haemophilia, 21 S2

Type: conference

A national survey of immunosuppression strategies for acquired haemophilia A

P. Batty, B. Palmer, E. Chalmers, C. R. M. Hay, R. Liesner, S. Rangarajan, K. Talks, M. Williams, P. Collins & D. P. Hart, 2015, Haemophilia, 21(1), e73-e76

DOI: 10.1111/hae.12547

Type: article

Pharmacokinetic and pharmacodynamic properties of plasma-derived vs. recombinant factor IX in patients with hemophilia B: a prospective crossover study

J. Alamelu, D. Bevan, B. Sorensen & S. Rangarajan, 2014, Journal of Thrombosis and Haemostasis, 12(12), 2044-2048

DOI: 10.1111/jth.12756

Type: article

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011

Peter W Collins, Benedict P Palmer, Elizabeth A Chalmers, Daniel P Hart, Ri Liesner, Savita Rangarajan, Katherine Talks, Michael Williams & Charles R M Hay, 2014, Blood, 124(23), 3389-3397

DOI: 10.1182/blood-2014-07-580498

Type: article

Professor Savita Rangarajan

Connect with Savita

Publications